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Abstract
Phase Ⅲ evidence in the shape of a series of randomized 
controlled trials and meta-analyses has shown that 
laparoscopic gastrectomy is safe and gives better 
short-term results with respect to the traditional open 
technique for early-stage gastric cancer. In fact, in the 
East laparoscopic gastrectomy has become routine for 
early-stage gastric cancer. In contrast, the treatment of 
advanced gastric cancer through a minimally invasive way 
is still a debated issue, mostly due to worries about its 
oncological efficacy and the difficulty of carrying out an 
extended lymphadenectomy and intestinal reconstruction 
after total gastrectomy laparoscopically. Over the last 
ten years the introduction of robotic surgery has implied 
overcoming some intrinsic drawbacks found to be present 
in the conventional laparoscopic procedure. Robot-
assisted gastrectomy with D2 lymphadenectomy has been 
shown to be safe and feasible for the treatment of gastric 
cancer patients. But unfortunately, most available studies 
investigating the robotic gastrectomy for gastric cancer 
compared to laparoscopic and open technique are so far 
retrospective and there have not been phase III trials. 
In the present review we looked at scientific evidence 
available today regarding the new high-tech surgical 
robotic approach, and we attempted to bring to light the 
real advantages of robot-assisted gastrectomy compared 
to the traditional laparoscopic and open technique for the 
treatment of gastric cancer.
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Core tip: Laparoscopic gastrectomy has been shown 
to be a viable option for early gastric cancer, showing 
survival rates comparable to those of open procedure. 
However, there has been criticism concerning the routine 
use of laparoscopy in patients with advanced gastric 
cancer, principally because it adapts poorly to complex 
maneuvers like D2 lymphadenectomy. Robotic surgery 
has been shown to make certain laparoscopic procedures 
easier and safer. Reports have recently shown the 
ever increasing feasibility and safety of robotic assisted 
laparoscopic gastrectomy for gastric cancer, in some cases 
even proving superior to traditional laparoscopy. 
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INTRODUCTION
In 1991, Kitano et al[1] performed the first laparoscopically 
assisted gastrectomy for gastric cancer. Subsequently, 
under the impulse of level Ⅲ studies providing the 
evidence of the safety of laparoscopic assisted distal 
gastrectomy (LADG) for distal early-stage gastric 
cancer, several authors reported comparative studies 
with better short-term results in favor of this technique 
with respect to traditional open[2]. As a consequence 
laparoscopic gastrectomy (LG) has progressively spread 
worldwide, especially in the East, for the treatment of 
early gastric cancer[3,4]. On the other hand, the treatment 
of patients with advanced gastric cancer has always been 
considered difficult laparoscopically, thus techniques 
such as laparoscopic assisted total gastrectomy (LATG) 
and laparoscopic extended lymphadenectomy did not 
meet the same enthusiasm. As a result, the spread of 
laparoscopic surgery as a means of performing total 
gastrectomy and managing advanced gastric cancer was 
limited. This was mainly due to the technical difficulties 
and complexity of the D2 lymphadenectomy and the 
intestinal reconstruction after total gastrectomy[5,6]. 
Robot-assisted techniques have brought about im-
provements to certain surgical procedures, particularly 
those which require precise dissection, making it possible 
to resolve some of the innate limitations of laparoscopy. 
So over the years, robot-assisted gastrectomy (RAG) 
has become increasingly considered as a valid, yet still 
debatable, alternative to executing gastrectomy for 
gastric cancer, in particular for total gastric resection and 
extended lymph node dissection in advanced tumours[7-9]. 
We analyzed high-quality clinical trials by systematically 
reviewing the literature published so far in Pubmed 
comprehending robotic case series, as well as those 
studies that have compared RAG with LG and/or open 
gastrectomy for gastric cancer. Our intent is to verify if 
at present there is actual evidence of an advantage to 
robotic compared to laparoscopic and traditional open 
gastrectomy for gastric cancer.
Rational basis of robotic surgery as improvement of 
laparoscopy 
Areas of surgery necessitating precise movements have 
employed Robotic technology. In 1994 the da Vinci® 
Surgical System (Intuitive Surgical, Sunnyvale, California, 
United States) gained the approval of the United States 
Food and Drug Administration (FDA). The da Vinci® 
Surgical Robotic has undergone constant improvement 
over recent years, and now includes additional features 
including near-infrared technology, and facilitated set-up. 
The latest generation, which was released in 2014 and is 
known as the da Vinci Xi™ system, is less bulky and its 
arms are more ergonomic (Figure 1).
Robotic surgery eliminates some of the disadvantages 
of conventional laparoscopy. The principal drawbacks of 
conventional laparoscopy from a technical standpoint 
are: The instability of the two-dimensional (2D) camera; 
instruments with limited movement which augment 
the physiologic tremor of the surgeon’s hand, therefore 
limiting manipulative actions and increasing ergonomic 
discomfort. 
The robotic surgery system has the upper hand over 
laparoscopy when fine dissection is needed, eliminating 
the traces of physiologic human tremor, increasing 
dexterity through its typical internal articulated endoscopic 
wrist (EndoWrist™ System), and providing stereoscopic 
vision with 3D high-resolution images[10]. This allows 
surgeons to perform minimally invasive surgery with 
greater ease and safety, and more ergonomically. As 
a consequence it probably makes it possible for more 
surgeons to complete complex procedure in a minimally 
invasive fashion. 
Moreover, even if laparoscopic surgery may have 
an effect on the robotic gastrectomy learning process, 
robotic surgery appears to globally need less time to 
master compared to a laparoscopic procedure traditionally 
requiring a steep learning curve[11-14].
Main drawbacks of conventional laparoscopy in gastric 
cancer surgery 
Delicate maneuvers which necessitate excellent 
visualization and total precision such as intra-corporeal 
anastomosis and dissection of extra-perigastric lymph 
nodes along the major arterial structures are the principal 
pitfalls of conventional laparoscopic gastrectomy for 
gastric cancer. 
The far from perfect and often shallow angulation 
of the traditional unergonomic laparoscopic technique 
render the D2 lymphadenectomy especially hard and 
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demanding even for minimally-invasive surgeons who 
have been solidly trained. Areas which are quite hard 
to reach during laparoscopic lymphadenectomy include 
lymph node stations 4, 6, 9, 11p and 12a[15]. It may 
be linked to the risk of important blood loss which can 
occur particularly during the lymph node dissection 
around the infra pyloric area and the inferior mesenteric 
vein, including stations 6 and 14, and the supra 
pancreatic area including stations 7, 8, and 9[16]. Miura 
et al[15] indicated a far inferior amount of harvested 
lymph nodes obtained by laparoscopy in comparison to 
open surgery along the major gastric curvature (Nos. 
4 and 6) and second tier nodes along the celiac and 
splenic arteries (Nos. 9 and 11). Similarly, Bouras et 
al[17] showed a greatly inferior amount of lymph nodes 
harvested along the common hepatic artery in a series 
of laparoscopic distal gastrectomy procedures compared 
to open distal gastrectomy (ODG).
Main technical advantages of robotics over traditional 
laparoscopy in gastric cancer
The majority of resectable gastric cancer patients are 
advised to undergo gastrectomy with D2 lymph node 
dissection surgical procedure[18]. Thus, in gastric cancer 
treatment, in order to fit oncological criteria, minimally 
invasive procedures must entail proper lymphadenectomy, 
as in its traditional open counterpart.
It is widely accepted that D2 lympadenectomy 
is one of the most difficult steps of the laparoscopic 
gastrectomy procedure for gastric cancer. The certain 
advantage produced by the robotic system could be 
decisive in gastric cancer surgery, mainly ensuring an 
extremely precise and safe lymphadenectomy with 
reduced risk of vessel injury[19], thus making this phase 
a principal indicator for the robot-assisted technique. The 
advantages of robotic surgery, such as tremor filtration 
and articulated function of wristed instruments, would 
be particularly suitable for enabling more complete 
dissection in demanding areas such as the dorsal part 
of the pancreas and behind splenic vessels at the 
hilum, which are not easily identified and are difficult to 
reach with current laparoscopic instruments and camera 
system[20]. It is extremely hard to reach the back of the 
suprapancreatic lymphatic area laparoscopically, and the 
downward compression of the pancreas which is particular 
prominent through the laparoscopic instruments may 
lead to pancreatic damage and pancreatitis. In these 
sites especially, the EndoWrist® robotic property and a 
far more stable vision allow the surgeon to complete this 
surgical step more easily and safely in comparison to the 
laparoscopic counterpart. 
Robotic surgery also has the advantage of making 
intra-corporeal anastomosis easier, and therefore over-
comes one of the greatest limitations of traditional 
laparoscopy from a technical standpoint in carrying out 
digestive restoration. This is particularly true after total 
gastrectomy, otherwise made possible by extracorporeal 
anastomosis with a small mini-laparotomy. Placing a 
hand-sewn purse-string suture on the esophagus is 
made easier by using robotic assistance, and esophageal 
Figure 1  New-generation da Vinci Xi™; the system is more versatile and better manoeuvrable, the robotic arms are thinner and arranged in a more 
ergonomic way, enabling multiquadrant procedures without repositioning the system. 
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anastomosis can subsequently be carried out by using 
a circular stapler, as in open surgery[7,19]. Another 
option would be to carry out a full robotic hand-sewn eso-
phagojejunal anastomosis[21], possible because the 
robotic system gives surgeons the chance to suture 
more easily and with greater precision compared to 
laparoscopy, particularly in deep and narrow areas. Thus, 
increased know-how and confidence with the robotic 
system will enable the surgeon to perform high-precision 
and safer intra-corporeal sutures for patients undergoing 
digestive anastomosis.
LITERATURE EVIDENCE
Studies of feasibility and safety 
The earliest reports of robot-assisted gastrectomy (RAG) 
were published in 2003 by Hashizume et al[22] and 
Giulianotti et al[23]. Recent reports have shown the safety 
and viability of robotic gastrectomy for treating gastric 
cancer[24,25]. Table 1 summarizes some of the robotic case 
series published to date[7-9,26-34]. Most of the experience so 
far derives from non-randomized retrospective studies, 
while only one available clinical trial to date has been 
prospectively conducted[34]. The studies mainly hail from 
the East. In the western countries, reports on RAG are 
fewer and usually limited to smaller series. In 2007, in 
the United States Anderson et al[7] reported the results 
of the first western series including 7 gastric cancer 
patients who were submitted to robot-assisted subtotal 
gastrectomy, demonstrating that robotic gastrectomy 
was viable, even if no direct comparison with laparoscopy 
was made[7].
Several authors worldwide reported their experience 
on RAG for cancer and the largest single institution series 
investigating clinical and oncological outcomes so far 
include (Table 1): Song et al[9] in 2009, Jiang et al[29] in 
2012, Liu et al[31] and Park et al[32] in 2013, Tokunaga 
et al[34] in 2015, which included respectively 100, 120, 
104, 200 and 120 patients. These studies confirmed 
the safety and feasibility of RAG for cancer, essentially 
reporting a suitable amount of lymph nodes retrieved, 
but they did not furnish long-term survival data. Globally, 
among these various studies RAG appears to be safe 
in terms of the incidence and severity of postoperative 
complications. The morbidity rate ranges between 4.9% 
to 13%, with a mortality rate of 0%-6%, comparable 
to those of conventional gastric cancer surgery. Among 
reported potential advantages of the robotic procedure, 
Tokunaga et al[34] noted a very low incidence of intra-
abdominal infectious complications (3.3%) in a large 
cohort of gastric cancer patients (n = 120) submitted to 
total or subtotal gastrectomy.
Comparative studies
Despite the existence of numerous reports regarding 
the safety and feasibility of RAG, only few robotic 
comparative analysis investigated RAG vs laparoscopic 
and/or open gastrectomy (Table 2)[11,12,24,25,35-50]. Most 
studies comparing robotic gastrectomy with open and 
laparoscopic surgery are retrospective case-control 
studies, almost all of these with sample sizes of fewer than 
100 cases. Only one multi-centre comparative study was 
prospectively conducted: Kim et al[50], compared a total 
of 434 gastric cancer patients submitted to robotic and 
laparoscopic gastrectomy (223 vs 211 respectively), and 
showed similar overall complications rate with no operative 
mortality in either group, at the expense of significantly 
higher operative time and higher costs of the robotic 
group. 
However, initial outcome demonstrated comparable 
or superior short-term results of RAG than the results 
achieved by open and laparoscopic procedures, at the 
price of generally longer operation time, as well as higher 
cost. The prolonged operation time is attributable also to 
the additional time docking the robotic system, however 
that time decreases gradually as the expertise of the 
team increases, and robotic devices are upgraded[9]. 
Multiple series have reported various ranges in morbidity 
(5%-17%) after RAG (Table 2). Essentially, outcomes 
shown in these studies are satisfactory and similar 
to those of traditional surgical procedures (Table 2). 
Aforementioned outcomes demonstrate the clinical 
feasibility in using robotic radical gastrectomy for gastric 
adenocarcinoma in comparison with the conventional 
open and traditional minimally invasive laparoscopic 
approach, in some cases with potential clinical advan-
tages also. For example, Kim et al[44] and Suda et al[49] 
showed a statistically significant improvement of the 
postoperative morbidity rate in gastric cancer patients 
submitted to RAG compared to LAG. In particular, Suda 
et al[49] noted that local (particularly pancreatic fistula, 
robotic 0% vs conventional laparoscopy 4.3%, P = 0.029) 
rather than systemic complication rates were attenuated 
using the surgical robot. Also Seo et al[47] reported an 
advantages of RAG in comparison to LAG in terms of a 
reduction of the incidence of postoperative pancreatitis 
or pancreatic fistula, which has been attributed to what 
is assumed to be a more gentle and steady pancreatic 
compression through the robotic system compared to 
laparoscopy during the suprapancreatic lymph nodes 
dissection. 
For the first time Kim et al[36] reported the results 
achieved with robotic surgery with respect to laparoscopic 
and open gastrectomy for the treatment of early gastric 
cancer. They compared 16 patients who underwent 
robotic procedure with 11 and 12 laparoscopic and open 
gastrectomy respectively, revealing longer operative 
times of the robotic group, but less bleeding and reduced 
length of hospital stay. With regards to number of har-
vested lymph nodes and post-operative outcomes am-
ongst the groups no difference was demonstrated. 
The biggest (not meta-analyzed) comparative 
study so far was carried out by Kim et al[41]. They 
retrospectively looked at data on surgical complications 
of 5839 gastric cancer patients (4542 open, 861 laparo-
scopic and 436 robotic gastrectomies), and found no 
Caruso S et al . Robot gastrectomy
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significant differences between the three groups with 
regards to post-operative complication and morbidity.
In another large single institute comparative study[25] 
the authors made a comparison between 236 patients 
who had undergone robotic curative resection of gastric 
cancer and 591 laparoscopic surgery patients (Table 2). 
The authors revealed a statistical significance difference, 
the mean duration of surgery was 49 min longer in 
the robotic group, whereas blood loss was 56.3 mL 
less. Morbidity, mortality and number of lymph nodes 
retrieved per level were comparable. 
In yet another large comparative study (39 patients 
with gastric cancer undergoing robotic, 586 open and 
64 laparoscopic gastrectomies)[39], RAG was linked to 
diminished bleeding and reduced hospital stay, but 
with longer operative time than was necessary for both 
open and laparoscopic gastrectomy. The amount of 
harvested lymph nodes was also similar between the 
open and robotic groups, but less in the laparoscopic 
group (Table 2). The authors especially underlined that 
robotic instruments made it a great deal more simple 
to carry out the lymph node dissection, rather than the 
conventional laparoscopic approach, more so in the 
infra-pyloric and supra-pancreatic stations.
Junfeng et al[24] retrospectively compared 120 vs 394 
gastric cancer patients who had undergone RAG and 
laparoscopic assisted gastrectomy (LAG) respectively, 
revealing similar results. However, it is interesting to 
note that the authors showed, in addition to once more 
less intra operative bleeding and longer RAG operative 
time compared to the laparoscopic counterpart, that 
the numbers of harvested lymph nodes were notably 
superior in the RAG group at tier 2. In the same way, 
Kim et al[44] commented that, with regard to their 
experience achieved on 87 gastric cancer patients who 
had undergone robot-assisted distal gastrectomy (RADG) 
compared to 288 submitted to LADG, RADG seemed to 
be advantageous over LADG in performing the dissection 
of the second level lymph nodes, in particular those 
located in the suprapancreatic space and those around 
the splenic artery. Also Son’s et al[45] showed that robotic 
gastric surgery gave a much larger amount of harvested 
lymph nodes around splenic vessels in comparison to 
lymph nodes retrieved during laparoscopic procedure. 
This current medical research evidence, albeit initial, 
seems to consolidate the advantage of robotic surgery 
over LAG in its ability to perform a more complete 
D2 lymphadenectomy, probably making it possible to 
overcome one of the greatest surgical drawbacks of the 
laparoscopy in the treatment of gastric cancer. 
An advantage of RAG compared to LAG has been 
reported in terms of a reduction of the incidence of 
postoperative pancreatitis or pancreatic fistula. This has 
been attributed to what is assumed to be a more gentle 
and constant pancreatic compression obtained using 
the robotic system compared to laparoscopy during the 
suprapancreatic lymph nodes dissection, i.e., at station 9 
and 11[47].
Review and meta-analysis studies
To date, several review articles[10,19,51-55] have been pub-
lished which provide a critical appraisal of the effectiveness 
of RAG for gastric cancer, but they are not systematic 
research and do not actually supply any statistical 
Table 1  Robot-assisted laparoscopic gastrectomy series for treatment of gastric cancer
Ref. Country Patients 
(n )
Stage 
disease
Resection type Operative 
time1 (min ± 
SD)
Blood loss1 
(mL ± SD)
Open 
conversion 
(%)
Harvested 
nodes1 (n  
± SD)
Morbidity 
(%)
Mortality 
(%)
Hospital stay1 
(d ± SD)Total Subtotal
Anderson et 
al[7]
United 
States
    7 0-Ⅰ-II -     7 420 ± NR 300 ± NR   0 24 ± NR .   0       4 ± NR
Patriti et al[8] Italy   3 Ⅰ-Ⅱ-Ⅲ     4     9 286 ± 32.6 03 ± 87.5   0 28. ± 8.3   7.7   0 .2 ± 4.3
Song et al[9] South 
Korea
00 Ⅰ-Ⅱ-Ⅲ   33   67 23.3 ± 43.2 28.2 ± 27.5   0 36.7 ± NR 3      7.8 ± 7.
Pugliese et 
al[26]
Italy   8 All 
stages
-   8 344 ± 62 90 ± 48 2 25 ± 4.5   6   6    0 ± 3
Lee et al[27] South 
Korea
  2 Ⅰ -   2 253.7 ± 53.0 35.8 ± 33.9   0 46.0 ± 25.5   8.3   0   6.6 ± .6
D’Annibale et 
al[28]
Italy   24 Ⅰ-Ⅱ-Ⅲ      3 267.5 ± NR 30 ± NR   0 28 ± NR   8.3   0      6 ± NR
Jiang et al[29] China 20 Ⅰ-Ⅱ-Ⅲ   35   85 245 ± 50 70 ± 45   0.9 22.5 ± 0.7   5   0   6.3 ± 2.6
Isogaki et al[30] Japan   6 Not 
reported
  4   47 520 ± 77 TG 
388 ± 85 SDG
50 ± 234 
TG 6.8 ± 
46.5 SDG
  0 43 ± 4 TG 
42 ± 8 
SDG
  4.9   .6 3.3 ± NR
Liu et al[3] China 04 Ⅰ-Ⅱ-Ⅲ   54   50 272.52 ± 53.9 80.78 ± 32.37   2 23. ± 5.3 .5   0   6.2 ± 2.5
Park et al[32] South 
Korea
200 All 
stages
  46 54 248.8 ± 55.6 46. ± 30.3   7 37.9 ± NR 0   0.5   8.0 ± 3.7
Coratti et al[33] Itlay   98 All 
stages
  38   60 296. ± NR 05.4 ± NR   7. 30.6 ± NR 2.   4.   8.7 ± NR
Tokunaga et 
al[34]
Japan 20 Ⅰ   2 08 348.5 ± NR 9 ± NR   2.5 44 ± NR 4.2   0      9 ± NR
Mean value. SD: Standard deviation; NR: Not reported; TG: Total gastrectomy; SDG: Subtotal distal gastrectomy. 
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comparative analysis. Thus, the usefulness of these articles 
is essentially of scientific expounding and debating, they 
do not add any new knowledge to that so far evidenced 
by clinical studies.
On the other hand, 9 meta-analysis[20,56-63] conducted 
using a systematic method have been published to date 
in literature trying to focus on RAG utility in treating 
gastric cancer (Table 3). One meta-analysis included 
certain reports which compared RAG to OG[57]; 5 meta-
analyses utilized high quality studies which compared 
RAG and LG[56,59-61,63]; and the remaining 3 meta-analyses 
contained a systematic review and meta-analysis of 
studies investigating short-term results of RAG vs LG 
and OG[20,58,62]. Exclusively prospective and retrospective 
Table 2  Comparative case-control studies of robot-assisted gastrectomy vs  laparoscopic assisted gastrectomy and/or open gastrectomy
Ref. Subject Stage 
disease
    Patients (n ) Operation 
time (min)1
Blood loss 
(mL)1
Harvested 
nodes (n )1
Morbidity 
(%)
Mortality (%) Hospital stay 
(d)1
RAG LAG OG
Song et al[35] RAG vs 
iLAG2 vs 
rLAG2
Ⅰ-Ⅱ   202   202
  202 
- 230 vs 289.5 
vs 34. (RAG 
< iLAG > 
rLAG)3
94.8 RAG vs 
39.5 rLAG 
(NS)
35.3 vs 3.5 vs 
42.7 (NS)
5 vs 5 vs 0 
(NS)
0 vs 0 vs 0 5.7 vs 7.7 vs 6.2 
(RAG < iLAG)3 
(RAG~rLAG, 
NS)
Kim et al[36] RAG vs LAG 
vs OG
Ⅰ-Ⅱ-
Ⅲ
  6      2 259.2 vs 203.9 
vs 26.7 (RAG 
> LAG > OG)3
30.3 vs 44.7 vs 
78.8 (RAG < 
LAG < OG)3
4. vs 37.4 vs 
43.3 (NS)
0 vs 0 vs 20 
(NS)
0 vs 0 vs 0 5. vs 6.5 vs 6.7 
(RAG < LAG < 
OG)3
Eom et al[37] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  30   62 - 229. vs 89.4 
(RAG > LAG)3
52.8 vs 88.3 
(NS)
30.2 vs 33.4 
(NS)
3.3 vs 6.6 
(NS)
0 vs 0 7.9 vs 7.8 (NS)
Woo et al[25] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
236 59 - 29.5 vs 70.7 
(RAG > LAG)3
9.6 vs 47.9 
(RAG < LAG)3
39.0 vs 37.4 
(NS)
 vs 3.7 
(NS)
0.4 vs 0.3 (NS) 7.7 vs 7.0 (RAG 
> LAG)3
Caruso et al[38] RAG vs OG All 
stages
  29 - 20 290 vs 222 
(RAG > OG)3
97.6 vs 386. 
(RAG < OG)3
28.0 vs 3.7 
(RAG~OG)
0.34 vs 
0.04 (NS)
0 vs 3.3 (NS) 9.6 vs 3.4 (RAG 
< OG)3  
Huang et al[39] RAG vs LAG 
vs OG
Ⅰ-Ⅱ-
Ⅲ
  39   64 586 430 vs 350 vs 
320 (RAG > 
LAG > OG)3
50 vs 00 vs 
400 (RAG < 
LAG < OG)3
32 vs 26 vs 34 
(RAG = OG > 
LAG)3
5.4 vs 5.6 
vs 4.7 (NS)
.4 vs .6 vs 2.6 
(NS)
7 vs  vs 2 
(RAG < LAG < 
OG)3
Uyama et al[40] RAG vs LAG All 
stages
  25 225 - 36 vs 345 
(NS)
5.8 vs 8.0 
(RAG < LAG)3
44.3 vs 43.2 
(NS)
.2 vs 6.9 
(NS)
0 vs 0 2. vs 7.3 
(RAG < LAG)3
Kang et al[2] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
00 282 - 202.05 vs 
73.45 (RAG > 
LAG)3
93.25 vs 73.45 
(RAG < LAG)3 
NR 4.0 vs 0.3 
(NS)
0 vs 0 9.8 vs 8. 
(RAG > LAG)3
Kim et al[4] RAG vs LAG 
vs OG
0-Ⅰ-
Ⅱ-Ⅲ
436 86 4542 226 vs 76 vs 
58 (RAG > 
LAG > OG)3
85 vs 2 vs 
92 (RAG = 
LAG < OG)3
40.2 vs 37.6 vs 
40.5 (RAG = 
OG > LAG)3
0. vs 0.4 
vs 0.7 (NS)
0.5 vs 0.3 vs 0.5 
(NS)
7.5 vs 7.8 vs 0.2 
(RAG = LAG < 
OG)3 
Yoon et al[42] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  36   65 - 305.8 vs 20.2 
(RAG > LAG)3
NR 42.8 vs 39.4 
(NS)
6.7 vs 5.4 
(NS)
0 vs 0 8.8 vs 0.3 (NS)
Hyun et al[43] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  38   83 - 234.4 vs 220.0 
(NS)
3.3 vs 30.48 
(NS)
32.8 vs 32.8 
(NS)
3.4 vs 
6.84 (NS)
0 vs 0 0.5 vs .9 (NS)
Kim et al[] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
72 48 - 206.4 vs 67. 
(RAG > LAG)3
59.8 vs 34.9 
(RAG < OG)3
37.3 vs 36.8 
(NS)
5.2 vs 4.2 
(NS)
0 vs 0.6 (NS) 7. vs 6.7 (NS) 
Kim et al[44] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  87 288 - 248.4 vs 230.0 
(RAG > LAG)3
NR 37. vs 34. 
(RAG > LAG)3
5.7 vs 9.0 
(RAG < 
LAG)3
. vs 0.3 (NS) 6.7 vs 7.4 (RAG 
< LAG)3
Son et al[45] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  5   58 - 264. vs 20.3 
(RAG > LAG)3
63.4 vs 20.7 
(NS)
47.2 vs 42.8 
(NS)
6 vs 22  
(NS)
.9 vs 0 (NS) 8.6 vs 7.9 (NS)
Park et al[46] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  30 20 - 28 vs 40 
(RAG > LAG)3
75 vs 60 (NS) 34 vs 35 (NS) 7 vs 7.5 
(NS)
0 vs 0 7.0 vs 7.0 (NS)
Junfeng et al[24] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
20 394 - 234.8 vs 22.3 
(RAG > LAG)3
8.3 vs 37.6 
(RAG < LAG)3
34.6 vs 32.7 
(RAG > LAG)3
5.8 vs 4.3 
(NS)
NR 7.8 vs 7.9 (NS)
Seo et al[47] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  40   40 - 243 vs 224 
(NS)
76 vs 227 
(RAG < LAG)3
40.4 vs 35.4 
(NS)
NR NR 6.75 vs 7.37 
(RAG < LAG)3
Shen et al[48] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
  93 330 - 257. vs 226.2 
(RAG > LAG)3
76.6 vs 22.5 
(RAG < LAG)3
33.0 vs 3.3 
(RAG > LAG)3
9.8 vs 0.0 
(NS)
NR 9.4 vs 0.6 (NS)
Suda et al[49] RAG vs LAG All 
stages
  88 438 - 38 vs 36 
(RAG > LAG)3
46 vs 34 (RAG 
> LAG)3
40 vs 38 (NS) 2.3 vs .4 
(RAG < 
LAG)3
. vs 0.2 (NS) 4 vs 5 (RAG < 
LAG)3
Kim et al[50] RAG vs LAG Ⅰ-Ⅱ-
Ⅲ
223 2 - 226 vs 80 
(RAG > LAG)3
50 vs 60 (NS) 33 vs 32 (NS) 3.5 vs 4.2 
(NS)
0 vs 0 7.8 vs 7.9 (NS)
Mean value; 2The authors compared 20 gastric cancer patients who underwent robotic gastrectomy with 20 initial patients who underwent laparoscopic 
subtotal gastrectomy (iLAG) and 20 recent laparoscopic subtotal gastrectomy performed during the same period as the 20 robotic gastrectomy (rLAG); 
3Difference statistically significant, P < 0.05; 4Major complications rate base on Clavien-Dindo classification ≥ 3, such as anastomotic and duodenal leakage. 
RAG: Robot-assisted laparoscopic gastrectomy; LAG: Laparoscopic assisted gastrectomy; OG: Open gastrectomy; NR: Not reported; NS: Not statistically 
significant difference. 
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studies were included in these meta-analysis, while no 
randomized controlled trials (RCTs) were found. The 
aforementioned meta-analysis showed that the RAG 
short-term clinical results were basically to be compared 
to LG and OG results. In terms of bleeding in particular, 
RAG was superior to both LG and OG, in spite of longer 
operation time. In addition RAG and LG groups did 
not show differences with regards to the number of 
harvested lymph nodes and conversion to open rates; 
RAG comported slightly inferior hospital stay or similar 
to that for LAG, but much less than OG; complications 
occurring after the operation were similar for all three 
operating methods. 
Robotic surgery lasts longer mainly because of the 
additional set-up and docking-time necessary for the 
robotic system. However, it must be said that operating 
time noticeably diminished as surgical experience in 
robotic gastrectomy increased[9,32,46]. Moreover, there are 
major limits to how these meta-analysis are interpreted. 
All data came from non-randomized controlled trials, and 
the included studies are essentially limited in number 
and with small sample sizes. Moreover, significant 
heterogeneity exists among the included studies deriving 
from several factors, such as different surgeon skill 
levels, different types of gastrectomy, different extent of 
lymph node dissection, different tumour stage, different 
rate of adjuvant treatment, and different protocols of 
post-operative management and discharge of patients. 
Thus, the overall level of clinical evidence of this pooled 
data was low and, since there have been no randomized 
comparative studies, even if a meta-analysis is 
performed, it seems difficult to reach a clear conclusion.
Long term outcome 
At the present time, long-term benefits of RAG for 
the treatment of gastric cancer are under reported in 
literature. Pugliese et al[26] are among the few who have 
reported long term results in their minimally invasive 
surgical experience in gastric cancer patients. Among 
a cohort-case study of 70 patients who underwent 
minimally invasive subtotal gastrectomy with D2 
lymphadenectomy, the authors included also 18 patients 
submitted to the robotic procedure. The authors did not 
provide data specifically referred to the robotic group 
only, however, always on the basis of analogous short-
term results between groups undergoing laparoscopic 
and robotic procedures, the reported 5-year survival was 
81% for the whole cohort. Coratti et al[33] were the first 
to report long-term survival data specifically referring 
to gastric cancer patients submitted to robot-assisted 
gastrectomies. They analyzed survival results in a group 
of 98 patients with either early and advanced gastric 
cancer submitted to RAG. In a mean follow-up of 46.9 
mo, they registered a cumulative 5-year survival rate 
of 73.3%. Son et al[45] carried out the longest follow-
up study till now available. They evaluated the survival 
rates in a cohort-study group of 51 gastric cancer 
patients submitted to robotic total gastrectomy with D2 
lymph nodes dissection and compared it to 58 patients 
who underwent analogous surgery but through the 
laparoscopic approach. In a median long-term follow-up 
of 70 mo, the authors did not find significant differences 
Table 3  Meta-analysis comparing robot-assisted gastrectomy with laparoscopic assisted gastrectomy and/or open gastrectomy in the 
treatment gastric cancer
Ref. Subject     Patients (n ) Operation time 
(min)1
Blood loss 
(mL)1
Harvested 
nodes (n )1 
Morbidity 
(%)
Mortality (%) Hospital stay 
(d)1 
RAG LAG OG
Xiong et al[56] RAG vs LAG 268   650 - 68.772 (RAG > 
LAG)3
-4.882 (RAG 
< LAG)3
-0.72 (NS) 0.744 (NS) .804 (NS) -0.542 (NS)
Liao et al[57] RAG vs OG 520 - 5260 65.732 (RAG > 
LAG)3
-26.082 (RAG 
< LAG)3
-0.782 (NS) 0.984 (NS) 0.984 (NS) -2.872 (RAG < 
LAG)3
Hyun et al[58] RAG vs LAG 
RAG vs OG
634
558
236
-
-
530
6.992 (RAG > 
LAG)3
65.732 (RAG > OG)3
-6.082 (NS)
-54.82 (RAG 
< OG)3
-0.252 (NS)
-.32 (NS) 
.24 (NS)
.374 (NS)
NR
NR
-0.602 (NS)
-2.82 (RAG < 
OG)3
Marano et al[20] RAG vs OG 
RAG vs LAG
404
404
-
  845
  78
-
95.832 (RAG > OG)3 
63.702 (RAG > 
LAG)3
-225.582 (NS)
-35.532 (RAG 
< LAG)3
-2.682 (NS)
0.502 (NS)
0.934 (NS) 
0.874 (NS)
NR
NR
-2.922 (RAG < 
OG)3
-0.602 (NS)
Xiong et al[59] RAG vs LAG 736 759 - 48.642 (RAG > 
LAG)3
-33.562 (RAG 
< LAG)3
.282 (NS) .34 (NS) .664 (NS) -.62 (NS)
Liao et al[60] RAG vs LAG 762 473 - 50.02 (RAG > LAG)3 -46.972 (RAG 
< LAG)3
.62 (NS) 0.884 (NS) 0.454 (NS) -0.52 (NS)
Shen et al[6] RAG vs LAG 506 369 - 48.462 (RAG > 
LAG)3
-38.432 (RAG 
< LAG)3
.062 (NS) 0.954 (NS) NR -.02 (NS)
Zong et al[62] RAG vs OG 
RAG vs LAG
48
997
-
2207
4674
 -
68.472 (RAG > OG)3
57.52 (RAG > 
LAG)3
-06.632 (RAG 
< OG)3
-28.592 (NS)
-0.782 (NS)
-0.632 (NS)
0.924 (NS)
.064 (NS)
0.724 (NS)
.054 (NS)
-2.492 (RAG < 
OG)3 
 -0.62 (NS)
Chuan et al[63] RAG vs LAG 55 245 - 42.92 (RAG > LAG)3 -6.072 (RAG 
< LAG)3
2.452 (NS) .054 (NS) NR -.982 (RAG < 
LAG)3
Mean value; 2Weighted mean difference; 3Difference statistically significant, P < 0.05; 4Odds ratio. RAG: Robot-assisted laparoscopic gastrectomy; LAG: 
Laparoscopic assisted gastrectomy; OG: Open gastrectomy; NR: Not reported; NS: Not statistically significant difference. 
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in overall survival and disease-free survival between the 
two groups. Specifically, the authors reported a 5-year 
overall survival rate of 89.5% for the robotic group, which 
was not statistically significant different with respect to 
the rate revealed in the laparoscopic group (91.1%).
The aforementioned results are comforting, but it 
must be said that the case studies were limited, and 
selection bias is a real worry as it was a non-randomized 
study design. Follow-up periods longer than 5 years are 
needed to show oncological results, and so further RCTs 
are required in order to validate definitive conclusions. 
DISCUSSION 
The relative new technological advance in surgery 
through the introduction of minimally invasive technique 
can be accepted as an alternative to open surgery, which 
usually confers better short-term post-operative results, 
only if the oncologic parameters are as sufficiently 
respected as for the traditional open approach. Obviously, 
at the same time the long-term survival rates should not 
be adversely affected either.
With specific reference to gastric cancer one of 
the most important oncological criterion is the quality 
of lymphadenectomy, thus in order for laparoscopic 
or robot-assisted laparoscopic gastric surgery to be 
considered adequate, at least the same extent of lymph 
node dissection as in traditional surgery should be 
achieved, and moreover favorable postoperative results 
should also be evident. 
Over the last two decades LG with lymph node 
dissection has developed as minimally invasive surgery 
for gastric cancer and it has been principally applied to 
early gastric cancer. Certain RCTs and meta-analysis 
showed that laparoscopic gastrectomy did not have 
inferior oncologic results compared to open surgery for 
early-stage gastric cancer, with instead improved results 
in the short term[3,64,65]. In fact, laparoscopic extended D1 
lymphadenectomy may be seen as sufficient for almost 
all early gastric cancer in which lymph node metastases 
rarely occur, and is today the recommended approach in 
the East. On the other hand, only few high quality reports 
investigating the oncological adequacy of laparoscopic 
minimally invasive techniques for advanced gastric 
cancer are available to date. Recently, some meta-
analyses related to this have been published, but there 
have been contrasting outcomes, particularly regarding 
complications after total gastrectomy and the actual 
adequacy of D2 lymphadenectomy in patients affected 
by advanced-stage of gastric cancer[4,64,66-69]. Even though 
a complete LG and extended lymph nodes dissection 
has been demonstrated by several experts to be feasible 
laparoscopically[5,6,26,70], due to some intrinsic limiting 
drawbacks of the laparoscopic technique, important 
oncologic preoccupations have been raised. When in the 
meta-analysis studies data not restricted to LADG solely 
for early gastric cancer was considered, but instead 
included advanced-stage tumour too, it was not possible 
to guarantee the same amount of lymph node dissection 
as in conventional surgical procedures[71,72]. Thus, the 
laparoscopic techniques cannot be considered a standard 
validated procedure for all gastric cancer sufferers.
Certain inherent drawbacks of conventional laparo-
scopy may be eliminated by robotics by increasing the 
use of minimally invasive procedures, especially when 
more extended lymph nodes dissection and complicated 
reconstruction are required. In light of this, the introduction 
of robotic technologies could lead to the improvement of 
health care and final results. Particularly during typical 
difficult maneuvers in laparocopy, such as the dissection 
of the lymphatic tissue around major abdominal vessels 
(gastric, gastroepiploic, common hepatic, and celiac 
artery lymph nodes), robotics offers some indisputable 
advantages, which make it possible to perform the 
dissection more safely and easily. Consequently, robotic 
techniques should be viewed more as a technical 
advancement and auxiliary tool of the traditional mini-
mally invasive laparoscopic approach, rather than an 
independent device system.
Most surgeons who are experts in robotics reported 
in their experience amounts of retrieved lymph nodes 
during RAG similar to those obtainable by the classic 
open counterpart procedure and sometimes more than 
those achieved by laparoscopy[8,20,38,56-63]. However, it 
must be said that the explanation of available comparable 
data among RAG, LG and OG has notable limitations. 
The principal issue that could affect the interpretation 
of these data is essentially the lack of a comprehensive 
comparative RCT. However, we have also to consider that 
the number of published high quality observational and 
retrospective studies is limited, and globally the sample 
sizes in each singular trial is poor. Ultimately, but not 
less importantly from the point of view of oncological 
adequacy, the duration of follow up is almost always 
limited.
CONCLUSION
RAG appears to be a safe and feasible alternative to 
conventional open or laparoscopic gastrectomy for the 
treatment of early stage gastric carcinoma, having 
demonstrated satisfactory perioperative outcomes and 
oncological adequacy. The number of collected lymph 
nodes when comparing RAG to open and laparoscopic 
gastrectomy are essentially similar when considering early-
stage gastric cancer only, while an advantageous lower 
blood loss estimation was revealed in comparison with the 
other two approaches.
Basically the robotic system simplifies certain hard 
conventional laparoscopy techniques and renders them 
safer, in addition simultaneously possessing a learning 
curve and reproducibility that appear to be briefer than 
conventional laparoscopy[11-14]. These results, albeit 
initial, are promising, but the superiority of robotic gastric 
surgery over the traditional laparoscopic approach 
has not yet been solidly proved and its validation is 
still a long way off for all gastric cancer patients. The 
main controversial issue regards the possibility of 
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demonstrating that the supposed superiority of RAG with 
respect to laparoscopy in carrying out a more adequate 
extended lymphadenectomy could lead to potential 
oncological benefit, probably true in gastric cancer of a 
more advanced stage.
Unfortunately, due to inadequate long-term follow-
up results and a limited number of studies to date 
available, larger and randomized prospective trials are 
required to draw definitive conclusion.
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